The DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Current Concepts of Psoriasis Immunopathogenesis
Open accessAbstract
Psoriasis is a recurrent, chronic, immune-mediated, systemic inflammatory disease of the skin, joints, and other organic systems. After atopic dermatitis, chronic stationary psoriasis is the most common inflammatory skin disease, affecting an average of 2–4% of the world’s population. The disease carries a significant burden due to its numerous comorbidities and the major impact on patients’ social and emotional aspects of life. According to current knowledge, psoriasis is a multifactorial disease that occurs in genetically predisposed individuals under various environmental factors, which trigger an immune response disorder with a series of complex inflammatory cascades. The disease is initiated and maintained by mutual interaction of the innate and adaptive immune cells, primarily dendritic cells, T lymphocytes, and keratinocytes, whose leading role alternates at different stages of the disease, consisting mainly in the IL-23/Th17 pathway. Inflammatory events result in consequent epidermal and dermal changes and evolution of the characteristic psoriatic phenotype, respectively. This paper aims to present a comprehensive overview of current knowledge on psoriasis genetic and environmental etiological factors, immunopathogenesis, and the leading cellular and cytokine participants in the inflammatory pathways of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Major effector cells and signaling pathways in the immunopathogenesis of psoriasis. The immunopathogenesis of psoriasis involves a complex inflammatory cascade, which is initially triggered by innate immune cells (keratinocytes, dendritic cells, NKT cells, macrophages). At the same time, the disease progresses and is maintained by their interaction with adaptive immune cells (T lymphocytes). The central mechanism of the disease is the IL-23/Th17 axis, whose executive cytokines IL-22 and IL-17A/F lead to keratinocyte proliferation, production of proinflammatory cytokines, chemokines and AMP, and the formation of a positive feedback loop, which maintains the inflammatory process. Cytokines in cells activate signaling and transcription pathways (cAMP, JAK-STAT), which achieve increased transcription of messenger genes and cytokines involved in the disease pathogenesis. Adapted from: [36].](/paper-figures/4d785ea27be945208028b01304a9a179/current-concepts-of-psoriasis-immunopathogenesis-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This keratinocyte activation amplifies the recruitment of neutrophils and additional CCR6+ Th17 cells, reinforcing the inflammatory infiltrate [23,25].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In psoriasis, histopathological findings include acanthosis, parakeratosis, neutrophilic microabscesses, and prominent dermal vascular proliferation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Th17-derived cytokines, particularly IL-17A, IL-17F, and IL-22, act directly on keratinocytes, inducing hyperproliferation, impaired terminal differentiation, and a marked increase in the production of chemokines such as CXCL1, antimicrobial peptides, and pro-inflammatory mediators.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“These reflect activation of the IL-23/Th17 axis.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psoriasis Pathogenesis and Treatment
Rendón, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,196
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P. A., Kasman, I. M., Eastham‐Anderson, J., Wu, J., & Ouyang, W. (2006) · Nature · doi:10.1038/nature05505 · Cited by 1,888
Lowes, M. A., Suárez‐Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,710
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D. E., Gudjonsson, J. E., Li, Y., Tejasvi, T., Feng, B., et al. (2009) · Nature Genetics · doi:10.1038/ng.311 · Cited by 1,433
Schweiger, D., Baufeld, C., Drescher, P., Oltrogge, B., Höpfner, S., Mess, A., Lüttke, J., Rippke, F., Filbry, A. W., & Max, H. (2013) · Skin Pharmacology and Physiology · doi:10.1159/000348473 · Cited by 1,349
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S. K., Langan, S., Mehta, N. N., Ogdie, A., Voorhees, A. S. V., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,228
A systematic review of worldwide epidemiology of psoriasis
Michałek, I. M., Loring, B., & John, S. M. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13854 · Cited by 1,158
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,126
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C. L., Matheson, R. T., Zachariae, C. O. C., Cameron, G. S., LI, L. C., Edson‐Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 933
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C. L., Menter, A., Ortonne, J. P., Krueger, J. G., Kricorian, G., Aras, G. A., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 932
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D. D., Wang, F., Chamian, F. N., Dhodapkar, M. V., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 900
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, A., & Chiricozzi, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8702-3 · Cited by 821
Arican, O., Aral, M., Sasmaz, S., & Ciragil, P. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.273 · Cited by 805
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Martínez‐Lostao, L., Anel, A., & Pardo, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0685 · Cited by 766
Chan, J. R., Blumenschein, W. M., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S. J., Lucian, L., Geissler, R. H., Brodie, S. J., Kimball, A. B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060244 · Cited by 691
Risk Factors for the Development of Psoriasis
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184347 · Cited by 686
Mechanisms of natural killer cell-mediated cellular cytotoxicity
Prager, I., & Watzl, C. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-269r · Cited by 636
Kryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Wang, Y., Liu, Y., Welling, T. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4733 · Cited by 474
Pathogenesis of psoriasis and development of treatment
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14139 · Cited by 470
New insights of T cells in the pathogenesis of psoriasis
Cai, Y., Fleming, C., & Yan, J. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.15 · Cited by 389
Scanning the Immunopathogenesis of Psoriasis
Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., & Romanelli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010179 · Cited by 331
The role of IL ‐23 and the IL ‐23/ T H 17 immune axis in the pathogenesis and treatment of psoriasis
Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J. N., Boehncke, W., & Prinz, J. C. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14433 · Cited by 329
Laggner, U., Meglio, P. D., Perera, G. K., Hundhausen, C., Lacy, K. E., Ali, N., Smith, C. H., Hayday, A., Nickoloff, B. J., & Nestle, F. O. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100804 · Cited by 324
Interleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 318
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
Boehncke, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00579 · Cited by 314
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Solimani, F., Meier, K., & Ghoreschi, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02847 · Cited by 310
Lew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 282
Current knowledge on psoriasis and autoimmune diseases
McCormick, T. S., Ayala‐Fontanez, N., & Soler, D. C. (2016) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s64950 · Cited by 279
α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis
Conrad, C., Boyman, O., Tonel, G., Tun-Kyi, A., Laggner, U., de Fougerolles, A., Koteliansky, V., Gardner, H., & Nestle, F. O. (2007) · Nature Medicine · doi:10.1038/nm1605 · Cited by 264
Injection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis
Nickoloff, B. J., & Wrone-Smith, T. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65109-7 · Cited by 262
Update on psoriasis immunopathogenesis and targeted immunotherapy
Mahil, S. K., Capon, F., & Barker, J. N. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0539-8 · Cited by 256
Ottaviani, C., Nasorri, F., Bedini, C., Pità, O. D., Girolomoni, G., & Cavani, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200535243 · Cited by 248
Old and New Biological Therapies for Psoriasis
Rønholt, K., & Iversen, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112297 · Cited by 241
Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study
Springate, D. A., Parisi, R., Kontopantelis, E., Reeves, D., Griffiths, C. E. M., & Ashcroft, D. M. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15021 · Cited by 238
Psoriasis: from Pathogenesis to Targeted Therapies
Conrad, C., & Gilliet, M. F. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8668-1 · Cited by 234
The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach
Krijgsman, D., Hokland, M., & Kuppen, P. J. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00367 · Cited by 230
Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
Benhadou, F., Mintoff, D., & del Marmol, V. (2018) · Dermatology · doi:10.1159/000495291 · Cited by 228
The Genetic Basis of Psoriasis
Capon, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122526 · Cited by 227
Bonish, B. K., Jullien, D., Dutronc, Y., Huang, B. B., Modlin, R. L., Spada, F. M., Porcelli, S. A., & Nickoloff, B. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4076 · Cited by 215
Psoriasis and Cardiovascular Risk: A Comprehensive Review
Masson, W. M., Lobo, M., & Molinero, G. B. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01346-6 · Cited by 210
Clinical and biological impact of the exposome on the skin
Passeron, T., Krutmann, J., Andersen, M. L., Katta, R., & Zouboulis, C. C. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16614 · Cited by 205
Dand, N., Mahil, S. K., Capon, F., Smith, C. H., Simpson, M. A., & Barker, J. N. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3384 · Cited by 200
Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders
Schön, M. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01764 · Cited by 197
Chen, L., & Tsai, T. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16083 · Cited by 188
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis
Dand, N., Duckworth, M., Baudry, D., Russell, A., Curtis, C. J. C., Lee, S. H., Evans, I., Mason, K. J., Alsharqi, A., Becher, G., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.038 · Cited by 184
IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes‐Duculan, J., Cardinale, I. R., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman‐Yassky, E., Suárez‐Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 182
Hou, Y., Zhu, L., Tian, H., Sun, H.-X., Wang, R., Zhang, L., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0505-z · Cited by 179
Rousset, L., & Halioua, B. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14032 · Cited by 168
Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
Nakajima, K., Kanda, T., Takaishi, M., Shiga, T., Miyoshi, K., Nakajima, H., Kamijima, R., Tarutani, M., Benson, J., Elloso, M. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000148 · Cited by 167
Chemerin/chemR23 axis in inflammation onset and resolution
Mariani, F., & Roncucci, L. (2014) · Inflammation Research · doi:10.1007/s00011-014-0792-7 · Cited by 166
Advances in Understanding the Immunological Pathways in Psoriasis
Georgescu, S. R., Tampa, M. Ş., Căruntu, C., Sârbu, M. I., Mitran, C. I., Mitran, M.-I., Matei, C., Constantin, C., & Neagu, M. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030739 · Cited by 156
Alwan, W., & Nestle, F. O. (2015) · PubMed · Cited by 148
Targeting CD8+ T cells prevents psoriasis development
Meglio, P. D., Villanova, F., Navarini, A. A., Mylonas, A., Tosi, I., Nestle, F. O., & Conrad, C. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.046 · Cited by 145
Dendritic cells: The driver of psoriasis
Wang, A., & Bai, Y. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.15184 · Cited by 142
Nickoloff, B. J., Bonish, B. K., Huang, B. B., & Porcelli, S. A. (2000) · Journal of Dermatological Science · doi:10.1016/s0923-1811(00)00120-1 · Cited by 129
Psoriasis and Antimicrobial Peptides
Takahashi, T., & Yamasaki, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186791 · Cited by 128
Recent advances in understanding psoriasis
Eberle, F. C., Brück, J., Holstein, J., Hirahara, K., & Ghoreschi, K. (2016) · F1000Research · doi:10.12688/f1000research.7927.1 · Cited by 127
Johnson-Huang, L. M., Suárez‐Fariñas, M., Pierson, K. C., Fuentes‐Duculan, J., Cueto, I., Lentini, T., Sullivan-Whalen, M. M., Gilleaudeau, P., Krueger, J. G., Haider, A. S., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.458 · Cited by 119
Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
Harden, J. L., Johnson-Huang, L. M., Chamian, F. N., Lee, E., Pearce, T. E., Leonardi, C. L., Haider, A. S., Lowes, M. A., & Krueger, J. G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.046 · Cited by 116
Ogdie, A., Grewal, S. K., Noe, M. H., Shin, D. B., Takeshita, J., Fuxench, Z. C. C., Carr, R. M., & Gelfand, J. M. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.024 · Cited by 115
Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis
Yawalkar, N., Schmid, S., Braathen, L. R., & Pichler, W. J. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04222.x · Cited by 107
“Inflammatory skin march” in atopic dermatitis and psoriasis
Furue, M., & Kadono, T. (2017) · Inflammation Research · doi:10.1007/s00011-017-1065-z · Cited by 106
Tohyama, M., Hanakawa, Y., Shirakata, Y., Dai, X., Yang, L., Hirakawa, S., Tokumaru, S., Okazaki, H., Sayama, K., & Hashimoto, K. (2009) · European Journal of Immunology · doi:10.1002/eji.200939473 · Cited by 104
Role of Innate Immune Cells in Psoriasis
Sato, Y., Ogawa, E., & Okuyama, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186604 · Cited by 103
Machado‐Pinto, J., Diniz, M. D. S., & Bavoso, N. C. (2016) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20164169 · Cited by 102
New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis
Karczewski, J., Dobrowolska, A., Rychlewska-Hańczewska, A., & Adamski, Z. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1166214 · Cited by 96
All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis
Dhana, A. V., Yen, H., Yen, H., & Cho, E. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.12.037 · Cited by 96
Epidemiology of major chronic inflammatory immune-related skin diseases in 2019
Pezzolo, E., & Naldi, L. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1719833 · Cited by 96
Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function
Ippagunta, S. K., Gangwar, R., Finkelstein, D., Vogel, P., Pelletier, S. W., Gingras, S., Redecke, V., & Häcker, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606996113 · Cited by 84
Psoriasis and the TNF/IL23/IL17 axis
Furue, K., Ito, T., Tsuji, G., Kadono, T., & Furue, M. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06202-8 · Cited by 84
Bissonnette, R., Papp, K. A., Maari, C., Yao, Y., Robbie, G. J., White, W. I., Le, C., & White, B. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.042 · Cited by 83
Takeshita, J., Shin, D. B., Ogdie, A., & Gelfand, J. M. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.039 · Cited by 78
Psoriasis risk factors and triggers.
Lee, E. B., Wu, K. K., Lee, M. P., Bhutani, T., & Wu, J. J. (2018) · PubMed · Cited by 77
Dermal γδ T cells – What have we learned?
O’Brien, R. L., & Born, W. K. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.01.011 · Cited by 76
Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation
Wang, Y., Edelmayer, R. M., Wetter, J., Salte, K. M., Gauvin, D. M., Leys, L. J., Paulsboe, S. E., Su, Z., Weinberg, I., Namovic, M. T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41655-7 · Cited by 76
The panoply of αβT cells in the skin
Nomura, T., Kabashima, K., & Miyachi, Y. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.07.010 · Cited by 69
Samotij, D., Nedoszytko, B., Bartosińska, J., Batycka-Baran, A., Czajkowski, R., Dobrucki, I. T., Dobrucki, L. W., Górecka-Sokołowska, M., Janaszak‐Jasiecka, A., Krasowska, D., et al. (2020) · Advances in Dermatology and Allergology · doi:10.5114/ada.2020.94832 · Cited by 69
Gandhi, M. A., Alwawi, E. A., & Gordon, K. B. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.02.001 · Cited by 68
Santus, P., Rizzi, M., Radovanovic, D., Airoldi, A., Cristiano, A., Conic, R. R. Z., Petrou, S., Pigatto, P. D. M., Bragazzi, N. L., Colombo, D., et al. (2018) · BioMed Research International · doi:10.1155/2018/3140682 · Cited by 65
Psoriasis and Inflammatory Bowel Disease
Cottone, M., Sapienza, C., Macaluso, F. S., & Cannizzaro, M. (2019) · Digestive Diseases · doi:10.1159/000500116 · Cited by 65
Immunological Memory of Psoriatic Lesions
Owczarczyk-Saczonek, A. B., Krajewska–Włodarczyk, M., Kasprowicz‐Furmańczyk, M., & Placek, W. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020625 · Cited by 64
Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease
Benhadou, F., Glitzner, E., Brisebarre, A., Swedlund, B., Song, Y., Dubois, C., Rozzi, M., Paulissen, C., del Mármol, V., Sibilia, M. C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax5849 · Cited by 64
Increased airway inflammation in patients with psoriasis
Damiani, G. B., Radaeli, A., Olivini, A., Calvara-Pinton, P., & Malerba, M. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14546 · Cited by 60
Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C
Downs, A. M., & Dunnill, M. G. S. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00655-4.x · Cited by 59
Nedoszytko, B., Szczerkowska‐Dobosz, A., Stawczyk‐Macieja, M., Owczarczyk-Saczonek, A. B., Reich, A., Bartosińska, J., Batycka-Baran, A., Czajkowski, R., Dobrucki, I. T., Dobrucki, L. W., et al. (2020) · Advances in Dermatology and Allergology · doi:10.5114/ada.2020.96243 · Cited by 56
The role of regulatory T cells and anti-inflammatory cytokines in psoriasis
Owczarczyk-Saczonek, A. B., Czerwińśka, J., & Placek, W. J. (2018) · Acta Dermatovenerologica Alpina Pannonica et Adriatica · doi:10.15570/actaapa.2018.4 · Cited by 54
Innate Lymphocytes in Psoriasis
Polese, B., Zhang, H., Thurairajah, B., & King, I. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00242 · Cited by 54
Dunphy, S., & Gardiner, C. M. (2011) · BioMed Research International · doi:10.1155/2011/248317 · Cited by 53
Cytokines of the IL‐17 family in psoriasis
Lauffer, F., Eyerich, K., Boehncke, W., Asadullah, K., Beissert, S., Ghoreschi, K., & Schön, M. P. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14124 · Cited by 51
Dermal γδ T cells — A new player in the pathogenesis of psoriasis
Cai, Y., Fleming, C., & Yan, J. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.02.018 · Cited by 48
Melanocytes: Target Cells of an HLA-C*06:02–Restricted Autoimmune Response in Psoriasis
Prinz, J. C. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.023 · Cited by 48
Skewed distribution of natural killer cells in psoriasis skin lesions
Batista, M. D., Ho, E. L., Kuebler, P., Milush, J. M., Lanier, L. L., Kallas, E. G., York, V. A., Chang, D., Liao, W. J., Unemori, P., et al. (2012) · Experimental Dermatology · doi:10.1111/exd.12060 · Cited by 45
Malerba, M., Damiani, G. B., Radaeli, A., Ragnoli, B., Olivini, A., & Calzavara‐Pinton, P. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13988 · Cited by 45
Interleukin-22 and Its Correlation with Disease Activity in Plaque Psoriasis
Wawrzycki, B., Pietrzak, A., Grywalska, E., Krasowska, D., Chodorowska, G., & Roliński, J. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0527-5 · Cited by 45
Integrative Biology Approach Identifies Cytokine Targeting Strategies for Psoriasis
Perera, G. K., Ainali, C., Semenova, E., Hundhausen, C., Barinaga, G., Kassen, D., Williams, A. E., Mirza, M. M., Balázs, M., Wang, X., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007217 · Cited by 44
Lorthois, I., Asselineau, D., Seyler, N., & Pouliot, R. (2017) · Mediators of Inflammation · doi:10.1155/2017/7215072 · Cited by 44
Liao, Y., Jee, S., Sheu, B., Huang, Y. L., Tseng, M.-P., Hsu, S. M., & Tsai, T. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07301.x · Cited by 40
Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?
Alexander, H., & Nestle, F. O. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000358 · Cited by 40
Perforin expression is upregulated in the epidermis of psoriatic lesions
Kaštelan, M., Massari, L. P., Gruber, F., Zamolo, G., Žauhar, G., Čoklo, M., & Rukavina, D. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06168.x · Cited by 39
Self-citationMetabolic syndrome and psoriasis: a study in 97 patients
Ferdinando, L. B., Fukumoto, P. K., Sanches, S., Fabrício, L. H. Z., & Skare, T. L. (2018) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.64.04.368 · Cited by 38
Nanodermatology‐based solutions for psoriasis: State‐of‐the art and future prospects
Damiani, G. B., Pacifico, A., Linder, D., Pigatto, P. D. M., Conic, R. R. Z., Grada, A. A., & Bragazzi, N. L. (2019) · Dermatologic Therapy · doi:10.1111/dth.13113 · Cited by 33
Dunphy, S., Sweeney, C. M., Kelly, G. A., Tobin, A., Kirby, B., & Gardiner, C. M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.10.004 · Cited by 32
SIMONE, C. D., Caldarola, G., Moretta, G., Piscitelli, L., Ricceri, F., & Prignano, F. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06255-7 · Cited by 31
Curry, J. L., Qin, J., Robinson, J. K., & Nickoloff, B. J. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-0289-roriin · Cited by 30
Damiani, G. B., Bragazzi, N. L., McCormick, T. S., Pigatto, P. D. M., Leone, S., Pacifico, A., Tiodorović, D., Franco, S. D., Alfieri, A., & Fiore, M. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i6.1002 · Cited by 29
A Role for KIR Gene Variants Other Than KIR2DS1 in Conferring Susceptibility to Psoriasis
Płoski, R., Łuszczek, W., Kuśnierczyk, P., Nockowski, P., Cisło, M., Krajewski, P., & Malejczyk, J. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.04.001 · Cited by 23
Analysis of perforin expression in peripheral blood and lesions in severe and mild psoriasis
Massari, L. P., Kaštelan, M., Laškarin, G., Zamolo, G., Massari, D., & Rukavina, D. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.02.007 · Cited by 21
Self-citationThe role of invariant T cells in inflammation of the skin and airways
Yip, K. H., Papadopoulos, M., Pant, H., & Tumes, D. J. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00740-9 · Cited by 21
Systemic and Local Increase of Granulysin Expression in Cytotoxic Lymphocytes in Severe Psoriasis
Vičić, M., Kaštelan, M., Tokmadžić, V. S., & PrpićMassari, L. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3298 · Cited by 19
Self-citationThe Role of CD8+ T-Cells and their Cytokines in the Pathogenesis of Psoriasis.
Volarić, I., Vičić, M., & Massari, L. P. (2019) · PubMed · Cited by 18
Self-citationCytotoxic T lymphocytes as a potential brake of keratinocyte proliferation in psoriasis
Vičić, M., Peternel, S., Simonić, E., Tokmadžić, V. S., Massari, D., Brajac, I., Kaštelan, M., & Massari, L. P. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.12.004 · Cited by 13
Self-citationDifferential Skewing of Circulating MR1-Restricted and γδ T Cells in Human Psoriasis Vulgaris
Plužarić, V., Štefanić, M., Mihalj, M., Levak, M. T., Muršić, I., Glavaš‐Obrovac, L., Petřek, M., Balogh, P., & Tokić, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572924 · Cited by 13
Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis
Antoniu, S. A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.712112 · Cited by 12
More tolerance for dendritic cells in psoriasis
Buhl, T., Saleh, M. M., & Schön, M. P. (2016) · Experimental Dermatology · doi:10.1111/exd.13153 · Cited by 9
Cited by
Sorted by citations
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 489
Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis
Kamata, M., & Tada, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941071 · Cited by 204
Psoriatic Arthritis: Pathogenesis and Targeted Therapies
Azuaga, A., Ramírez, J., & Cañete, J. D. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054901 · Cited by 205
Bi, D., Qu, F., Xiao, W., Wu, J., Liu, P., Du, H., Xie, Y., Liu, H., Zhang, L., Tao, J., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c08979 · Cited by 189
Comprehensive Insight into Lichen Planus Immunopathogenesis
Vičić, M., Hlača, N., Kaštelan, M., Brajac, I., Tokmadžić, V. S., & Massari, L. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033038 · Cited by 123
Self-citation
Metadata
- Authors
- Vičić, M., Kaštelan, M., Brajac, I., Sotošek, V., & Massari, L. P.
- Affiliations
- University of Rijeka (HR)
- Department of Anesthesiology, Reanimation and Intensive Care, Medical Faculty University of Rijeka, Clinical Hospital Center Rijeka, Tome Strižića 3, 51000 Rijeka, Croatia
- Corresponding author
- Massari, Larisa Prpić
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-10-26
- Volume
- 22
- Issue
- 21
- Pages
- 11574
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8584028
- OpenAlex
- W3209863967
- Cited by
- 163
- References
- 115
- Citations by year
- 2026: 32 · 2025: 36 · 2024: 48 · 2023: 26 · 2022: 19 · 2021: 2
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Rijeka (biomed-uniri-18-43)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, immunopathogenesis, IL-23/Th17 pathway, dendritic cells, T cells, keratinocytes, innate and adaptive immunity, genetic susceptibility, environmental factors, cytokines, skin inflammation, comorbidities
- MeSH terms
- Animals, Humans, Inflammation, Phenotype, Psoriasis, Signal Transduction, Keratinocytes, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
